Early discontinuation may be overestimated if treatment occurred outside the purview of the claims data source 13 KESIMPTA received approval in August 2020, resulting in a relatively limited number of patients with sufficient real-world follow-up data to assess persistence and adherence
taking a tailored approach ensures you reach your desired goal more quickly
Stay hydrated like your glow depends on it (because it does)
XS: Methodology, Supervision, Writing review & editing
most patients communicate through the portal Treatments Offered Weekly GLP-1 injections: compounded semaglutide, Ozempic, Wegovy, compounded tirzepatide, Mounjaro, Zepbound Oral alternative: My Custom Weight Loss Kit (metformin, bupropion, naltrexone, inositol, vitamins B6 and B12) Bottom Line Eden Health keeps semaglutide access simple with predictable monthly costs and built-in coaching, ideal if you want clinical care plus support without paying extra